Emgality 120 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F72XS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,240
Award facts
- Contract value 100% obligated
- $2,239.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,239.68 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen medication, with a completion date of December 11, 2025. This is a firm fixed price, non-set-aside contract to be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contract portfolio with DLA focused on delivering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The company's federal procurement track record demonstrates consistent capability to compete and win non-set-aside contracts through open competition, serving critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Emgality, a CGRP receptor antagonist used for migraine treatment, exemplifies the company's role as a key vendor supporting military medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26F72XS?
SPE2DR26F72XS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F72XS worth?
The government has obligated $2,240 on SPE2DR26F72XS.
Is contract SPE2DR26F72XS an order under another contract?
Yes. SPE2DR26F72XS is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F72XS competed?
The extent of competition for SPE2DR26F72XS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award